Cutaneous Oncology
Blackwell Science Inc. (Verlag)
978-0-86542-517-0 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
This book was written to full a perceived void among current publications. Cutaneous Oncology was designed to focus on the nature and behaviour of cancers, standing at the junction of clinical medicine and basic science research to provide a "total picture" of skin tumor biology to both clinicians and researchers. The book explains our clinical understandings of skin cancer in terms of their biological and molecular bases, and provide a framework of
Part I Cutaneous Carcinogenesis; 1. History of Cutaneous Carcinogenesis; 2. Multistage Mouse Model of Skin Carcinogenesis and Cell Cycle Cancer Development; 3. Molecular Model of Cancer Development; 4. Development of Metastases; 5. Immune Surveillance Mechanisms; 6. Skin Cancer in the Immunosuppressed Host; 7. Differentiation Pathways and Cutaneous Carcinogenesis: Alterations in Differentiation, in Control of the Cell Cycle, and in Induction of Apoptisis in Skin Cancer; 8. Cytokines and Growth Factors; 9. Retinoids; 10. The Role of Aging; 11. Tumor-Stromal Interactions in Cutaneous Carcinogenesis; 12. Tumor Dormancy; 13. DNA Damage and Repair; Etiologic Factors; 14. Mechanisms of Cutaneous Malignancies; 15. Epidemiology of Ultraviolet Radiation; 16. The Ozone Layer; 17. Ionizing Radiation; 18. Chemicals; 19. Viruses; 20. Genetic Syndromes Predisposing to Skin Cancer Development: Prevention of Skin Cancer; 21. The Public Health Approach; 22. Chemoprevention; Part II Malignant Melanoma; 23. History of Malignant Melanoma; 24. Molecular Biology; 25. Cell Structure and Function; 26. Cellular Immunobiology; 27. Effects of Biological Factors; 28. Precursor Melanocytic Lesions; 29. Environmental and Host Factors; 30. Pregnancy and Estrogen; 31. Follow-up of Patients at Risk; 32. Clinical Presentation; 33. Histology; 34. Factors Predictive of Metastasis and Outcome; 35. Clinical Presentation and Diagnosis or Metastasis; 36. Therapy of Melanoma In-situ (Lentigo Maligna); 37. Surgical Treatment of Stage I and II Disease (Excision, Lymphadenectomy, Limb Perfusion); 38. Radiation Therapy of Stage I and II Disease; 39. Adjuvant Therapy of Stage I and II Disease; 40. Therapy of Stage III and IV Disease; 41. New Horizons in Melanoma Treatment; Part III Squamous Cell Carcinoma; 42. History of Squamous Cell Carcinoma; 43. Molecular Biology; 44. Cell Structure and Function; 45. Cell Immunobiology; 46. Effects of Biological Factors; 47. Etiologic Risk Factors; 48. Predisposing Genetic Syndromes and Clinical Settings; 49. Clinical Presentation; 50. Histology; 51. Features Associated with Recurrence; 52. Features Associated with Metastatis; 53. Surgical Management of Local Disease; 54. Cryosurgery; 55. Radiation Therapy; 56. Lasers and Photodynamic Therapy; 57. Biological Response Modifiers; 58. Topical Chemotherapy; 59. Therapy of Advanced Disease - Surgery and Radiation Therapy; 60. Therapy of Advanced Disease: Chemotherapy and Biologic Response Modifiers; 61. Follow-up and Prevention; 62. Research Techniques and New Horizons; Part IV Basal Cell Carcinoma; 63. History of Basal Cell Carcinoma; 64. Pathogenesis; 65. Molecular Genetics; 66. Cell Structure and Function; 67. Cellular Immunobiology; 68. Effects of Biological Factors; 69. Aggressive verus Non-Aggressive Subtypes; 70. Etiologic Risk Factors; 71. Predisposing Genetic Syndromes and Clinical Settings; 72. Clinical Presentation; 73. Histology; 74. Features Associated with Basal Cell Carcinoma; 75. Features Associated with Metastasis; 76. Surgical Management of Local Disease; 77. Cryosurgery; 78. Radiation Therapy of Local Disease; 79. Lasers and Photodynamic Therapy; 80. Biogical Response Modifiers; 81. Topical Chemotherapy; 82. Adjuvant Therapy of Local Disease; 83. Prevention of Non-melanoma Skin Cancer and Early Detection of Recurrence and New Tumors; 84. Regional and Distant Metastatic Disease; 85. Research Techniques and New Horizons; Part V Other Cutaneous Tumours; 86. Merkel Cell Carcinoma; 87. Microcystic Adnexal Carcinoma; 88. Primary Cutaneous Adenoid Cystic Carcinoma; 89. Malignant Eccrine Spiradenoma; 90. Malignant Clear Cell Hidradenoma; 91. Malignant Chondroid Syringoma; 92. Eccrine Porocarcinoma; 93. Mucinous Carcinoma; 94. Malignant Cylindroma; 95. Malignant Hidradenoma Papilliferum; 96. Apocrine Carcinoma; 97. Paget's Disease of the Nipple; 98. Extramammary Paget's Disease; 99. Malignant Ceruminomas; 100. Sebaceous Gland Carcinoma; 101. Pilomatrizoma Carcinoma; 102. Overview of Soft Tissue Sarcomas; 103. Dermatofibrosarcoma Protruberans; 104. Fibrosarcoma; 105. Atypical Fibroxanthoma; 106. Malignant Fibrous Histiocytoma; 107. Liposarcoma; 108. Angiosarcoma; 109. Kaposi's Sarcoma; 110. Hemangiopericytoma; 111. Leiomysarcoma; 112. Cutaneous Rhabdomyosarcoma; 113. Malignant Peripheral Nerve Sheath Tumor; 114. Malignant Granular Cell Tumor; 115. Epithelioid Sarcoma; 116. Cutaneous T-Cell Lymphoma; 117. B-Cell Lymphomas; 118. Cancers Metastatic to Skin
| Erscheint lt. Verlag | 4.2.1998 |
|---|---|
| Zusatzinfo | 628 |
| Verlagsort | Oxford |
| Sprache | englisch |
| Maße | 279 x 203 mm |
| Gewicht | 3207 g |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Dermatologie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
| ISBN-10 | 0-86542-517-5 / 0865425175 |
| ISBN-13 | 978-0-86542-517-0 / 9780865425170 |
| Zustand | Neuware |
| Haben Sie eine Frage zum Produkt? |
aus dem Bereich
